Dawn C. Schwenke
Papers
1
Total Citations
52
H-Index
1
About
Dawn C. Schwenke is a leading researcher in clinical biochemistry and mass spectrometry, with a primary focus on the quantitative analysis of peptide hormones, particularly insulin-like growth factor 1 (IGF1). Her major contribution lies in advancing high-throughput mass spectrometric immunoassays for clinical diagnostics. In her highly cited 2014 work, she developed a parallel workflow enabling the analysis of over 1,000 samples per day for IGF1—a critical biomarker for managing growth hormone disorders. This innovation directly addressed the growing demand for reliable, scalable mass spectrometry-based methods in clinical settings, overcoming traditional throughput limitations. With over 50 citations, this paper has significantly influenced the adoption of MS-based IGF1 assays, improving the speed and accuracy of hormone monitoring. Schwenke’s work bridges the gap between cutting-edge analytical chemistry and practical clinical applications, making her a key figure in the evolution of high-throughput proteomics and endocrine diagnostics. Her research continues to shape how laboratories implement mass spectrometry for routine biomarker analysis.
Research Focus
Key Achievements
Top Papers
- 1